Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer

Joanne Collazo, Beibei Zhu, Spencer Larkin, Sarah K. Martin, H. Pu, Craig Horbinski, Shahriar Koochekpour, Natasha Kyprianou

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Cofilin (CFL) is an F-Actin-severing protein required for the cytoskeleton reorganization and filopodia formation, which drives cell migration. CFL binding and severing of F-Actin is controlled by Ser3 phosphorylation, but the contributions of this step to cell migration during invasion and metastasis of cancer cells are unclear. In this study, we addressed the question in prostate cancer cells, including the response to TGF-β, a critical regulator of migration. In cells expressing wild-type CFL, TGF-β treatment increased LIMK-2 activity and cofilin phosphorylation, decreasing filopodia formation. Conversely, constitutively active CFL (SerAla) promoted filipodia formation and cell migration mediated by TGF-β. Notably, in cocultures of prostate cancer epithelial cells and cancer-Associated fibroblasts, active CFL promoted invasive migration in response to TGF-β in the microenvironment. Further, constitutively active CFL elevated the metastatic ability of prostate cancer cells in vivo. We found that levels of active CFL correlated with metastasis in a mouse model of prostate tumor and that in human prostate cancer, CFL expression was increased significantly in metastatic tumors. Our findings show that the actin-severing protein CFL coordinates responses to TGF-β that are needed for invasive cancer migration and metastasis.

Original languageEnglish
Pages (from-to)2362-2373
Number of pages12
JournalCancer Research
Volume74
Issue number8
DOIs
Publication statusPublished - Apr 15 2014

Fingerprint

Actin Depolymerizing Factors
Prostatic Neoplasms
Cell Movement
Actins
Pseudopodia
Neoplasm Metastasis
Cofilin 2
Neoplasms
Phosphorylation
Coculture Techniques
Cytoskeleton
Prostate
Epithelial Cells

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Collazo, J., Zhu, B., Larkin, S., Martin, S. K., Pu, H., Horbinski, C., ... Kyprianou, N. (2014). Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer. Cancer Research, 74(8), 2362-2373. https://doi.org/10.1158/0008-5472.CAN-13-3058

Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer. / Collazo, Joanne; Zhu, Beibei; Larkin, Spencer; Martin, Sarah K.; Pu, H.; Horbinski, Craig; Koochekpour, Shahriar; Kyprianou, Natasha.

In: Cancer Research, Vol. 74, No. 8, 15.04.2014, p. 2362-2373.

Research output: Contribution to journalArticle

Collazo, J, Zhu, B, Larkin, S, Martin, SK, Pu, H, Horbinski, C, Koochekpour, S & Kyprianou, N 2014, 'Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer', Cancer Research, vol. 74, no. 8, pp. 2362-2373. https://doi.org/10.1158/0008-5472.CAN-13-3058
Collazo, Joanne ; Zhu, Beibei ; Larkin, Spencer ; Martin, Sarah K. ; Pu, H. ; Horbinski, Craig ; Koochekpour, Shahriar ; Kyprianou, Natasha. / Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer. In: Cancer Research. 2014 ; Vol. 74, No. 8. pp. 2362-2373.
@article{776d49aab2b14ca489cb0f808fcf81a4,
title = "Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer",
abstract = "Cofilin (CFL) is an F-Actin-severing protein required for the cytoskeleton reorganization and filopodia formation, which drives cell migration. CFL binding and severing of F-Actin is controlled by Ser3 phosphorylation, but the contributions of this step to cell migration during invasion and metastasis of cancer cells are unclear. In this study, we addressed the question in prostate cancer cells, including the response to TGF-β, a critical regulator of migration. In cells expressing wild-type CFL, TGF-β treatment increased LIMK-2 activity and cofilin phosphorylation, decreasing filopodia formation. Conversely, constitutively active CFL (SerAla) promoted filipodia formation and cell migration mediated by TGF-β. Notably, in cocultures of prostate cancer epithelial cells and cancer-Associated fibroblasts, active CFL promoted invasive migration in response to TGF-β in the microenvironment. Further, constitutively active CFL elevated the metastatic ability of prostate cancer cells in vivo. We found that levels of active CFL correlated with metastasis in a mouse model of prostate tumor and that in human prostate cancer, CFL expression was increased significantly in metastatic tumors. Our findings show that the actin-severing protein CFL coordinates responses to TGF-β that are needed for invasive cancer migration and metastasis.",
author = "Joanne Collazo and Beibei Zhu and Spencer Larkin and Martin, {Sarah K.} and H. Pu and Craig Horbinski and Shahriar Koochekpour and Natasha Kyprianou",
year = "2014",
month = "4",
day = "15",
doi = "10.1158/0008-5472.CAN-13-3058",
language = "English",
volume = "74",
pages = "2362--2373",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer

AU - Collazo, Joanne

AU - Zhu, Beibei

AU - Larkin, Spencer

AU - Martin, Sarah K.

AU - Pu, H.

AU - Horbinski, Craig

AU - Koochekpour, Shahriar

AU - Kyprianou, Natasha

PY - 2014/4/15

Y1 - 2014/4/15

N2 - Cofilin (CFL) is an F-Actin-severing protein required for the cytoskeleton reorganization and filopodia formation, which drives cell migration. CFL binding and severing of F-Actin is controlled by Ser3 phosphorylation, but the contributions of this step to cell migration during invasion and metastasis of cancer cells are unclear. In this study, we addressed the question in prostate cancer cells, including the response to TGF-β, a critical regulator of migration. In cells expressing wild-type CFL, TGF-β treatment increased LIMK-2 activity and cofilin phosphorylation, decreasing filopodia formation. Conversely, constitutively active CFL (SerAla) promoted filipodia formation and cell migration mediated by TGF-β. Notably, in cocultures of prostate cancer epithelial cells and cancer-Associated fibroblasts, active CFL promoted invasive migration in response to TGF-β in the microenvironment. Further, constitutively active CFL elevated the metastatic ability of prostate cancer cells in vivo. We found that levels of active CFL correlated with metastasis in a mouse model of prostate tumor and that in human prostate cancer, CFL expression was increased significantly in metastatic tumors. Our findings show that the actin-severing protein CFL coordinates responses to TGF-β that are needed for invasive cancer migration and metastasis.

AB - Cofilin (CFL) is an F-Actin-severing protein required for the cytoskeleton reorganization and filopodia formation, which drives cell migration. CFL binding and severing of F-Actin is controlled by Ser3 phosphorylation, but the contributions of this step to cell migration during invasion and metastasis of cancer cells are unclear. In this study, we addressed the question in prostate cancer cells, including the response to TGF-β, a critical regulator of migration. In cells expressing wild-type CFL, TGF-β treatment increased LIMK-2 activity and cofilin phosphorylation, decreasing filopodia formation. Conversely, constitutively active CFL (SerAla) promoted filipodia formation and cell migration mediated by TGF-β. Notably, in cocultures of prostate cancer epithelial cells and cancer-Associated fibroblasts, active CFL promoted invasive migration in response to TGF-β in the microenvironment. Further, constitutively active CFL elevated the metastatic ability of prostate cancer cells in vivo. We found that levels of active CFL correlated with metastasis in a mouse model of prostate tumor and that in human prostate cancer, CFL expression was increased significantly in metastatic tumors. Our findings show that the actin-severing protein CFL coordinates responses to TGF-β that are needed for invasive cancer migration and metastasis.

UR - http://www.scopus.com/inward/record.url?scp=84899538936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899538936&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-13-3058

DO - 10.1158/0008-5472.CAN-13-3058

M3 - Article

C2 - 24509905

AN - SCOPUS:84899538936

VL - 74

SP - 2362

EP - 2373

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 8

ER -